Strategic Analysis of Indian Biosimilar Market

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developments. The research deliverable also covers the overview of the other major biosimilar players like China. The research service also gives a deeper insight into the profiles of the companies that are into this segment in India. It also covers the historical trends and future impacts on Biosimilar Markets.

Table of Contents

Strategic Analysis of Indian Biosimilar Market, Executive SummaryBrief Summary of Indian Biosimilar MarketExecutive Summary of the Biosimilar marketFuture ImpactStrategic Analysis of Indian Biosimilar Market, Global Biosimilar MarketOverview of Global Biosimilar MarketIntroduction to BiosimilarsGlobal Population Demographics Key BiodrugsTypes of Products Manufactured by Major ParticipantsMarket Size of Biosimilars: GlobalMarket Size: Biologic Patents Expiring in 2011-2016Market Size: Biologics Patents Expiring 2016-2019Market Size : Worldwide Sales of Key Biodrugs Market Opportunities Market Size of Biosimilars: Revenue ForecastsMajor Participants - GlobalMajor Participants - TrendsStrategic Analysis of Indian Biosimilar Market, Indian Biosimilar MarketOverview if Indian Biosimilar MarketOverview of Indian Biosimilar MarketTimeline of Indian MarketIndian Market PortfolioDomestic Market PotentialMarket Drivers Ranked in Order of ImpactGeneral Factors favoring the marketMarket Restraints Ranked in Order of ImpactHurdles faced by Indian ParticipantsDomestic Market Potential - Observed Trends in MarketExport Potential - OverviewExport Potential - Expansion Strategy of Indian ParticipantsOverview of Highly Regulated Markets: EuropeOverview of Highly Regulated Markets: The United StatesOverview of Semi-regulated Markets: ChinaCost Advantage of IndiaBiosimilar Market in India: Revenue ForecastsStrategic Analysis of Indian Biosimilar Market, Regulatory ScenarioOverview of Regulatory ScenarioIndian Regulations for BiosimilarsInternational Regulatory Authorities European Medicines Agency (EMA)International Regulatory Authorities US-FDAStrategic Analysis of Indian Biosimilar Market, Major Participants in Indian MarketOverview of Major Participants in the Indian MarketBioconDr. Reddy’sRanbaxyWockhardtIntas Biopharmaceuticals Shantha BiotechStrategic Analysis of Indian Biosimilar Market, Historical Trends and Future ImpactOverview of Historical trends and Future Impact2001-2010: A Historical View of the Biosimilar Market2010-2015: Frost & Sullivan View on the Biosimilars MarketStrategic Analysis of Indian Biosimilar Market, Chinese Biosimilar MarketOverview of Chinese Biosimilar MarketOverview of Biosimilar Market in ChinaChina – Major ParticipantsStrategic Analysis of Indian Biosimilar Market, About Frost and SullivanFrost and Sullivan: OverviewWho is Frost and SullivanWhat makes us uniqueT.E.A.M. MethodologyGlobal Perspective




Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.